MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Cancer

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.26005PMID 21351092PMCID PMC3465713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2010

  2010cited by this paper
• Modeling metastasis biology and therapy in real time in the mouse lung.

  2010cited by this paper
• Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.

  2010cited by this paper
• Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

  2010cited by this paper
• Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence

  2009cited by this paper
• The current state of preclinical prostate cancer animal models

  2008cited by this paper
• Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients.

  2008cited by this paper
• Cancer micrometastasis and tumour dormancy  

  2008cited by this paper
• New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells.

  2008cited by this paper
• c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.

  2008cited by this paper
• Up‐regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia

  2007cited by this paper
• The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.

  2006cited by this paper
• Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

  2005cited by this paper
• Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.

  2005influential reference
• Rising prostate-specific antigen after primary prostate cancer therapy

  2005cited by this paper
• Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.

  2005cited by this paper
• The Drg-1 gene suppresses tumor metastasis in prostate cancer.

  2003cited by this paper
• The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

  2003cited by this paper
• Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone.

  2003cited by this paper
• Mechanisms of metastasis suppression by introduction of human chromosome 10 into rat prostate cancer.

  2002cited by this paper
• Suppression of metastasis of rat prostate cancer by introduction of human chromosome 13

  2002cited by this paper
• Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.

  2002cited by this paper
• Metastasis: Dissemination and growth of cancer cells in metastatic sites

  2002cited by this paper
• Suppression of metastasis of rat prostate cancer by introduction of human chromosome 13.

  2002cited by this paper
• Functional evidence for a metastasis suppressor gene for rat prostate cancer within a 60-kilobase region on human chromosome 8p21-p12.

  2002cited by this paper
• The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.

  2001cited by this paper
• Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.

  2001cited by this paper
• Localization of a novel tumor metastasis suppressor region on the short arm of human chromosome 2

  2000cited by this paper
• Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes.

  2000cited by this paper
• The Dunning model

  2000cited by this paper
• Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.

  1999cited by this paper
• Metastasis suppressor gene(s) for rat prostate cancer on the long arm of human chromosome 7

  1999cited by this paper
• Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer.

  1999cited by this paper
• Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.

  1998cited by this paper
• CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.

  1997cited by this paper
• Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.

  1997cited by this paper
• Flow cytometric evaluation of erythrocyte response to oxidant stress.

  1995cited by this paper
• KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2.

  1995cited by this paper
• Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11.

  1992cited by this paper
• Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers

  1987influential reference
• Effect of drug efflux blockers on vital staining of cellular DNA with Hoechst 33342.

  1987cited by this paper

• Sleepyhead, deadly awakening: the dynamics of metastatic organotropism, tumor dormancy and therapeutic implications

  2025cites this paper
• Evaluation of the association between the -1304T>G polymorphism in the promoter of the MKK4 gene and the risk of colorectal cancer: a PRISMA-compliant meta-analysis.

  2019cites this paper
• Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth

  2017cites this paper
• Downregulation of phosphorylated MKK4 is associated with a poor prognosis in colorectal cancer patients

  2017cites this paper
• Targeting metastasis

  2016cites this paper
• IDENTIFICATION OF NOVEL INHIBITORS FOR MITOGEN-ACTIVATED PROTEIN KINASE KINASE 4 BY VIRTUAL SCREENING AND MOLECULAR DYNAMICS SIMULATION TECHNIQUES

  2016cites this paper
• Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4) Promotes Human Prostate Cancer Metastasis

  2014cites this paper
• Hinokitiol Induces DNA Damage and Autophagy followed by Cell Cycle Arrest and Senescence in Gefitinib-Resistant Lung Adenocarcinoma Cells

  2014cites this paper
• Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer

  2014influential citation
• Delayed Cell Cycle Progression in Selenoprotein W-depleted Cells Is Regulated by a Mitogen-activated Protein Kinase Kinase 4-p38/c-Jun NH2-terminal Kinase-p53 Pathway*

  2012influential citation
• Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization

  2012cites this paper
• Using MKK4’s metastasis suppressor function to identify and dissect cancer cell–microenvironment interactions during metastatic colonization

  2012cites this paper
• Building on the foundation of daring hypotheses: Using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization

  2011cites this paper